VivoSeq
Other

Ovarian Stimulation

0

Pipeline Programs↗

16

Active Trials↗

4

Companies Involved↗

Ovarian Stimulation is an early-stage landscape with 0 programs across 4 companies. The most active players are Ferring, EMD Serono, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

33/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

79/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Ferring logo

Ferring

0 programs

PreclinicalEMD Serono logo

EMD Serono

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalChangchun GeneScience Pharmaceutical Co., Ltd. logo

Changchun GeneScience Pharmaceutical Co., Ltd.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

76

clinical trials

Completed38 · 50%
Unknown status12 · 16%
Recruiting9 · 12%
Terminated6 · 8%
Not yet recruiting4 · 5%
Withdrawn3 · 4%
Other4 · 5%

Clinical Trials

Trial Activity

76 trials

Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF
Recruiting·NNorthwest Women's and Children's Hospital, Xi'an, Shaanxi·N/A·NCT06023602·1,338 enrolled
Efficacy of Micronized Natural Progesterone Vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.
Recruiting·IInstituto Bernabeu·Phase 4·NCT05954962·150 enrolled
PErsonalized Addition of Recombinant LH in Ovarian Stimulation
Recruiting·FFundación Santiago Dexeus Font·Phase 4·NCT04719000·120 enrolled
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
Recruiting·UUniversity Hospital, Ghent·Phase 4·NCT06175832·60 enrolled
Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate
Recruiting·PPAEC General Hospital, Islamabad·Phase 4·NCT07462065·62 enrolled
One-shot Ovarian Stimulation Protocol (One-shot)
Recruiting·FFundación Santiago Dexeus Font·N/A·NCT06635538·20 enrolled
INTEnsity of ovariaN Stimulation and Embryo Quality
Recruiting·FFundación Santiago Dexeus Font·Phase 4·NCT04983173·110 enrolled
Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity
Recruiting·AART Fertility Clinics LLC·N/A·NCT06839274·100 enrolled
Assessment of the Role of Serum FSH Monitoring During Ovarian Stimulation and Identification of an Optimal Range for Expected Normal Responders
Recruiting·AART Fertility Clinics LLC·N/A·NCT06572930·150 enrolled
Letrozole 5 mg for 10 Days Versus Letrozole 10 mg for 5 Days for Ovarian Stimulation in PCOS
Active, not recruiting·—·N/A·NCT07448272·80 enrolled
PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)
Active, not recruiting·MMỹ Đức Hospital·N/A·NCT06378268·626 enrolled
Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings
Active, not recruiting·Ferring logoFerring·N/A·NCT06561958·1,500 enrolled
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
Not yet recruiting·—·Phase 2·NCT06212102·120 enrolled
FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients
Not yet recruiting·—·Phase 3·NCT06227949·140 enrolled
Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes
Not yet recruiting·NNesta Clinic·Phase 4·NCT06396390·152 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)